Cargando…

ADP-ribosylation of arginine

Arginine adenosine-5′-diphosphoribosylation (ADP-ribosylation) is an enzyme-catalyzed, potentially reversible posttranslational modification, in which the ADP-ribose moiety is transferred from NAD(+) to the guanidino moiety of arginine. At 540 Da, ADP-ribose has the size of approximately five amino...

Descripción completa

Detalles Bibliográficos
Autores principales: Laing, Sabrina, Unger, Mandy, Koch-Nolte, Friedrich, Haag, Friedrich
Formato: Texto
Lenguaje:English
Publicado: Springer Vienna 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102197/
https://www.ncbi.nlm.nih.gov/pubmed/20652610
http://dx.doi.org/10.1007/s00726-010-0676-2
_version_ 1782204357210537984
author Laing, Sabrina
Unger, Mandy
Koch-Nolte, Friedrich
Haag, Friedrich
author_facet Laing, Sabrina
Unger, Mandy
Koch-Nolte, Friedrich
Haag, Friedrich
author_sort Laing, Sabrina
collection PubMed
description Arginine adenosine-5′-diphosphoribosylation (ADP-ribosylation) is an enzyme-catalyzed, potentially reversible posttranslational modification, in which the ADP-ribose moiety is transferred from NAD(+) to the guanidino moiety of arginine. At 540 Da, ADP-ribose has the size of approximately five amino acid residues. In contrast to arginine, which, at neutral pH, is positively charged, ADP-ribose carries two negatively charged phosphate moieties. Arginine ADP-ribosylation, thus, causes a notable change in size and chemical property at the ADP-ribosylation site of the target protein. Often, this causes steric interference of the interaction of the target protein with binding partners, e.g. toxin-catalyzed ADP-ribosylation of actin at R177 sterically blocks actin polymerization. In case of the nucleotide-gated P2X7 ion channel, ADP-ribosylation at R125 in the vicinity of the ligand-binding site causes channel gating. Arginine-specific ADP-ribosyltransferases (ARTs) carry a characteristic R-S-EXE motif that distinguishes these enzymes from structurally related enzymes which catalyze ADP-ribosylation of other amino acid side chains, DNA, or small molecules. Arginine-specific ADP-ribosylation can be inhibited by small molecule arginine analogues such as agmatine or meta-iodobenzylguanidine (MIBG), which themselves can serve as targets for arginine-specific ARTs. ADP-ribosylarginine specific hydrolases (ARHs) can restore target protein function by hydrolytic removal of the entire ADP-ribose moiety. In some cases, ADP-ribosylarginine is processed into secondary posttranslational modifications, e.g. phosphoribosylarginine or ornithine. This review summarizes current knowledge on arginine-specific ADP-ribosylation, focussing on the methods available for its detection, its biological consequences, and the enzymes responsible for this modification and its reversal, and discusses future perspectives for research in this field.
format Text
id pubmed-3102197
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-31021972011-07-14 ADP-ribosylation of arginine Laing, Sabrina Unger, Mandy Koch-Nolte, Friedrich Haag, Friedrich Amino Acids Review Article Arginine adenosine-5′-diphosphoribosylation (ADP-ribosylation) is an enzyme-catalyzed, potentially reversible posttranslational modification, in which the ADP-ribose moiety is transferred from NAD(+) to the guanidino moiety of arginine. At 540 Da, ADP-ribose has the size of approximately five amino acid residues. In contrast to arginine, which, at neutral pH, is positively charged, ADP-ribose carries two negatively charged phosphate moieties. Arginine ADP-ribosylation, thus, causes a notable change in size and chemical property at the ADP-ribosylation site of the target protein. Often, this causes steric interference of the interaction of the target protein with binding partners, e.g. toxin-catalyzed ADP-ribosylation of actin at R177 sterically blocks actin polymerization. In case of the nucleotide-gated P2X7 ion channel, ADP-ribosylation at R125 in the vicinity of the ligand-binding site causes channel gating. Arginine-specific ADP-ribosyltransferases (ARTs) carry a characteristic R-S-EXE motif that distinguishes these enzymes from structurally related enzymes which catalyze ADP-ribosylation of other amino acid side chains, DNA, or small molecules. Arginine-specific ADP-ribosylation can be inhibited by small molecule arginine analogues such as agmatine or meta-iodobenzylguanidine (MIBG), which themselves can serve as targets for arginine-specific ARTs. ADP-ribosylarginine specific hydrolases (ARHs) can restore target protein function by hydrolytic removal of the entire ADP-ribose moiety. In some cases, ADP-ribosylarginine is processed into secondary posttranslational modifications, e.g. phosphoribosylarginine or ornithine. This review summarizes current knowledge on arginine-specific ADP-ribosylation, focussing on the methods available for its detection, its biological consequences, and the enzymes responsible for this modification and its reversal, and discusses future perspectives for research in this field. Springer Vienna 2010-07-21 2011 /pmc/articles/PMC3102197/ /pubmed/20652610 http://dx.doi.org/10.1007/s00726-010-0676-2 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Review Article
Laing, Sabrina
Unger, Mandy
Koch-Nolte, Friedrich
Haag, Friedrich
ADP-ribosylation of arginine
title ADP-ribosylation of arginine
title_full ADP-ribosylation of arginine
title_fullStr ADP-ribosylation of arginine
title_full_unstemmed ADP-ribosylation of arginine
title_short ADP-ribosylation of arginine
title_sort adp-ribosylation of arginine
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102197/
https://www.ncbi.nlm.nih.gov/pubmed/20652610
http://dx.doi.org/10.1007/s00726-010-0676-2
work_keys_str_mv AT laingsabrina adpribosylationofarginine
AT ungermandy adpribosylationofarginine
AT kochnoltefriedrich adpribosylationofarginine
AT haagfriedrich adpribosylationofarginine